1470P - First real life data on durvalumab after definitive concomitant chemoradiotherapy (cCRT) in unresectable stage (St) III non-small cell lung cancer (NSCLC) in France: Analysis of 591 patients (pts) enrolled in the French cohort (c) temporary authorization of use (ATU)
| Autor: | Avrillon, V. 1, Bota Ouchlif, S. 2, Merle, P. 3, Pichon, E. 4, Stancu, A.T. 5, Chouaid, C. 6, Sire, C. 7, Boudabous, H. 8, Lagrange, A. 9, Sabatini, M. 10, Eberst, G. 11, Boisselier, P. 12, Gourion, A. 13, Lion, A. 13, Lahouegue, A. 13, Belkhiria, K. 14, de La Porte, I. 14, Urbieta, M. 14, Mornex, F. 15, Girard, N. 16 |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v597-v597 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|